TTPH - Tetraphase Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5295.63M
Enterprise Value 3134.27M
Trailing P/E N/A
Forward P/E 1-2.66
PEG Ratio (5 yr expected) 1-0.01
Price/Sales (ttm)35.93
Price/Book (mrq)1.97
Enterprise Value/Revenue 316.32
Enterprise Value/EBITDA 6-1.18

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2016
Most Recent Quarter (mrq)Sep 30, 2017


Profit Margin 0.00%
Operating Margin (ttm)-1,391.01%

Management Effectiveness

Return on Assets (ttm)-41.75%
Return on Equity (ttm)-73.63%

Income Statement

Revenue (ttm)8.23M
Revenue Per Share (ttm)0.21
Quarterly Revenue Growth (yoy)378.50%
Gross Profit (ttm)5.14M
EBITDA -114.06M
Net Income Avi to Common (ttm)-113.74M
Diluted EPS (ttm)-2.85
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)161.36M
Total Cash Per Share (mrq)3.14
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)7.55
Book Value Per Share (mrq)2.92

Cash Flow Statement

Operating Cash Flow (ttm)-91.19M
Levered Free Cash Flow (ttm)-49.65M

Trading Information

Stock Price History

Beta 3.17
52-Week Change 336.34%
S&P500 52-Week Change 317.93%
52 Week High 39.93
52 Week Low 33.57
50-Day Moving Average 36.19
200-Day Moving Average 36.72

Share Statistics

Avg Vol (3 month) 3562.72k
Avg Vol (10 day) 3674.21k
Shares Outstanding 551.41M
Float 51.21M
% Held by Insiders 10.42%
% Held by Institutions 161.69%
Shares Short 33.14M
Short Ratio 37.42
Short % of Float 38.58%
Shares Short (prior month) 32.83M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 4N/A
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A